Lizzi C. Lee speaks with Gary Rieschel about what's behind China's biotech boom, potential risks, and long-term global ...

Chinese companies are involved in one-fifth of pharma’s clinical development programs, but trade wars and regulatory hurdles ...

Akeso's immunotherapy drug allowed half of its patients to go 11.1 months without their condition worsening Chinese drug ...

Last year, Summit Therapeutics ( SMMT 1.31%) was one of the stars of the biotech industry. The company's shares soared ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

China health care companies received a significant reprieve in terms of geopolitical risks when the US Senate declined to ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...

A European business lobby group urged China to take steps not to prioritise low prices over product safety in the country's ...

China issued the final version of its compliance guidelines for health care companies to prevent commercial bribery ...

With the fate of the BIOSECURE Act currently in limbo, WuXi AppTec is looking on the brighter side for 2025. | With the fate ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries to ...